SK-NEP-1Homo sapiens (Human)Cancer cell line

Also known as: SKNEP, SKNEP1, SKNEP-1

🤖 AI SummaryBased on 12 publications

Quick Overview

Human kidney tumor cell line with EWSR1-FLI1 fusion, used in Ewing sarcoma research.

Detailed Summary

SK-NEP-1 is a human kidney tumor cell line that has been extensively studied in the context of Ewing sarcoma. It is characterized by the presence of the EWSR1-FLI1 fusion gene, a hallmark of Ewing sarcoma family of tumors. This cell line has been used in various research applications, including the study of tumor biology, drug sensitivity, and molecular mechanisms underlying Ewing sarcoma. Despite its initial classification as a Wilms tumor cell line, subsequent molecular analyses have reclassified it as part of the Ewing sarcoma family. SK-NEP-1 is also notable for its use in preclinical testing of therapeutic agents and in understanding the genetic and molecular profiles of Ewing sarcoma. The cell line has been involved in studies related to gene expression, mutations, and chromosomal abnormalities associated with this type of cancer.

Research Applications

Ewing sarcoma researchGene expression analysisDrug sensitivity testingMolecular profiling

Key Characteristics

EWSR1-FLI1 fusionHuman kidney tumor originUsed in preclinical studies
Generated on 6/15/2025

Basic Information

Database IDCVCL_0631
SpeciesHomo sapiens (Human)
Tissue SourcePleural effusion[UBERON:UBERON_0000175]

Donor Information

Age25
Age CategoryAdult
SexFemale
Subtype FeaturesEWS-FLI

Disease Information

DiseaseEwing sarcoma
LineageBone
SubtypeEwing Sarcoma
OncoTree CodeES

DepMap Information

Source TypeAcademic lab
Source IDACH-001192_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Gly245Ser (c.733G>A)UnspecifiedSomatic mutation acquired during proliferationPubMed=28445466
Gene fusionEWSR1EWSR1-FLI1, EWS-FLI1-Type 1 fusionPubMed=15150091
Gene deletionCDKN2A-HomozygousPossiblePubMed=26870271

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10
D13S317
11
D16S539
11
D18S51
15,17
D19S433
12,14
D21S11
29,31
D2S1338
19,20
D3S1358
14,15
D5S818
13
D7S820
8,10
D8S1179
12
FGA
24
Penta D
11,12
Penta E
7,18
TH01
8,9.3
TPOX
8,11
vWA
15,19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

Are EWSR1-FLI-positive cell lines from patients with other diagnoses than Ewing sarcoma really Ewing sarcoma cell lines?

Staege M.S.

Pediatr. Blood Cancer 66:e27769.1-e27769.2(2019).

WARNING: G-401 and SK-NEP-1 cell lines are not Wilms tumor cell lines.

Pritchard-Jones K., Perotti D.

Pediatr. Blood Cancer 66:e27741.1-e27741.2(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.

Hsieh J.J.-D., Hakimi A.A.

Nat. Commun. 8:15165.1-15165.10(2017).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

The genomic landscape of the Ewing sarcoma family of tumors reveals recurrent STAG2 mutation.

Catchpoole D., Llombart-Bosch A., Waldman T., Khan J.

PLoS Genet. 10:E1004475-E1004475(2014).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

SK-NEP-1 and Rh1 are Ewing family tumor lines.";

Houghton P.J.

Pediatr. Blood Cancer 50:703-706(2008).

Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins.

Rousset M., Zweibaum A., Fogh J.

Cancer Res. 41:1165-1170(1981).

Human urologic cancer cell lines.";

Williams R.D.

Invest. Urol. 17:359-363(1980).

Human tumor lines for cancer research.";

Fogh J.

Cancer Invest. 4:157-184(1986).

Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Fogh J., Wright W.C., Loveless J.D.

J. Natl. Cancer Inst. 58:209-214(1977).

Cultivation, characterization, and identification of human tumor cells with emphasis on kidney, testis, and bladder tumors.

Fogh J.

Natl. Cancer Inst. Monogr. 49:5-9(1978).

One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.

Fogh J., Fogh J.M., Orfeo T.

J. Natl. Cancer Inst. 59:221-226(1977).

New human tumor cell lines.";

Fogh J., Trempe G.L.

(In book chapter) Human tumor cells in vitro; Fogh J. (eds.); pp.115-159; Springer; New York; USA (1975).